Immunoadhesins as research tools and therapeutic agents (Q41429628)

30 September 2017

1 reference

title

Immunoadhesins as research tools and therapeutic agents (English)

1 reference

30 September 2017

Ashkenazi A

1

1 reference

PubMed ID

9099788

30 September 2017

Chamow SM

series ordinal

2

1 reference

PubMed ID

9099788

30 September 2017

language of work or name

1 reference

1 April 1997

1 reference

Current Opinion in Immunology

30 September 2017

1 reference

30 September 2017

9

1 reference

30 September 2017

2

1 reference

30 September 2017

195-200

1 reference

Designing CD4 immunoadhesins for AIDS therapy

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Immunoadhesins: principles and applications

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Uptake of recombinant myeloperoxidase, free or fused to Fc gamma, by macrophages enhances killing activity toward micro-organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Generation of soluble interleukin-1 receptor from an immunoadhesin by specific cleavage

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Cleavable CD40Ig fusion proteins and the binding to sgp39.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

A lymphotoxin-beta-specific receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

cDNA cloning and characterization of a Cek7 receptor protein-tyrosine kinase ligand that is identical to the ligand (ELF-1) for the Mek-4 and Sek receptor protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Deleted in Colorectal Cancer (DCC) encodes a netrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Binding of cynomolgus monkey IgE to a humanized anti-human IgE antibody and human high affinity IgE receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

1 reference

7 January 2021

Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Fas involvement in cytotoxicity mediated by human NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Recent advances in tumor necrosis factor and CD40 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Inhibition of Sephadex-induced lung injury in the rat by Ro 45-2081, a tumor necrosis factor receptor fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980135-5

7 January 2021

10.1016/S0952-7915(97)80135-5

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9099788